Entrar Registro gratuito

4SC AG Renda

Qual é o Renda de 4SC AG?

O Renda de 4SC AG é -€18.99

Qual é a definição de Renda?

Lucro Líquido Disponível para os Acionistas Ordinários é igual ao lucro líquido menos os dividendos preferenciais pagos.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Renda de empresas na Setor Health Care em XETRA em comparação com 4SC AG

O que 4SC AG faz?

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

Empresas com renda semelhantes a 4SC AG